Your dermatology practice is not one business. It is three or four businesses sharing a waiting room, a tax ID, and a single profit-and-loss statement that quietly lies to you every month. The medical side runs on insurance contracts with steadily shrinking reimbursement. The Mohs suite runs on per-case surgical economics. The cosmetic side is a cash business with retail margins. When you blend them into one P&L, the winners subsidize the losers invisibly — and you make expansion decisions on averages that describe no part of your practice accurately.
Consider the stakes: cosmetic and non-surgical services now account for roughly half of dermatology industry revenue, while inflation-adjusted Medicare reimbursement for Mohs surgery's headline code has fallen about 46% over an 18-year span. One side of your practice is booming; another is being asked to do the same work for little more than half the real pay. If your books cannot show you each side separately, you are flying blind through exactly the crosscurrents that sink practices.
This guide shows how to structure your bookkeeping so each service line stands on its own numbers: medical dermatology, Mohs surgery, cosmetic services, retail products, and the dermatopathology lab decision.
Why One Blended P&L Hides the Truth
A typical full-service dermatology practice runs some combination of these profit centers:
- Medical dermatology — insured office visits, biopsies, destructions, and excisions. High volume, payer-dependent, and the most exposed to documentation-driven denials.
- Mohs surgery — staged skin-cancer surgery plus reconstruction. Strong per-case revenue, but reimbursement per stage has been grinding downward for years.
- Cosmetic dermatology — lasers, injectables, peels, and energy-based treatments. Cash-pay, highest margin, and the fastest-growing segment.
- Retail products — sunscreen, cleansers, and cosmeceuticals sold at the front desk or online. Essentially a small store inside your clinic.
- Dermatopathology lab — in-house slide reading that turns your biopsy volume into lab revenue instead of a reference-lab expense.
Each center has radically different economics. Industry benchmarking has shown a general-dermatology exam room running around 50% overhead while a procedure room runs closer to 32% — same building, same staff pool, completely different margin profiles. Roll them together and a thriving cosmetic arm can mask a medical side that is slowly bleeding from denials and prior-authorization labor. The fix is departmental accounting: every dollar of revenue and every traceable dollar of cost gets tagged to the profit center that earned or spent it.
Set Up Profit Centers in Your Chart of Accounts
You do not need new software to do this — you need discipline in the software you have. Most practice accounting systems support classes, departments, or tracking categories. Use them.
Revenue accounts per center. Break collections into at least: medical office visits, medical procedures, Mohs surgery, Mohs reconstruction, cosmetic services (by modality if volume justifies it — laser, injectables, facials), retail product sales, and pathology revenue. If your practice-management system exports a single "collections" line, fix the export mapping before you do anything else — aggregated imports defeat the entire exercise.
Direct costs per center. Tag what each center actually consumes: cosmetic injectable product and laser consumables to cosmetic; Mohs supplies, histotech labor, and slide materials to Mohs; cost of goods sold on every retail SKU to retail. Provider compensation follows the provider's time split — a physician assistant splitting time between medical clinic and cosmetic rooms should have compensation allocated accordingly, not dumped into one bucket.
Shared overhead by a defensible rule. Rent, front-desk labor, billing staff, the EHR, and marketing serve everyone. Allocate them by square footage, provider hours, or revenue share — pick one method per cost, document it, and keep it stable year over year so trends mean something. What matters is consistency, not theoretical perfection.
One KPI dashboard per center. Each profit center deserves the same short list of monthly metrics: gross collections, contractual adjustments and write-offs, net collection rate, direct-cost margin, fully loaded margin after allocated overhead, and revenue per encounter. The last one matters more than most owners think — consistently, the most profitable cosmetic practices are not the busiest by volume; they are the ones that maximize revenue per encounter.
Medical Dermatology: Win on Denials and Documentation, Not Volume
Medical dermatology is a margin game played against payers, and the books should reflect that. Your two most important numbers are the denial rate by payer and the cost of your revenue-cycle labor — particularly prior authorizations, whose administrative cost practices increasingly absorb without any offsetting payment.
Build these habits into your monthly close:
- Track denials by reason code, payer, and CPT code — not as one lump sum. "Missing medical necessity" on lesion destructions is a documentation problem with a specific fix; a spike from one payer on one code family is a contract or policy problem. You cannot tell them apart from a single write-off line.
- Hold surgical billing until the pathology report lands when the diagnosis drives code selection. For excisions and similar procedures, the histology result can change which CPT code the documentation supports. Billing the day of surgery and correcting later trades a small delay for a large denial-and-rework cost.
- Treat modifier 25 as a documentation product, not a reflex. When a significant, separately identifiable evaluation-and-management service happens on the same day as a procedure, the E/M code needs its own history, exam, and decision-making in the note. Payers have repeatedly tightened scrutiny here, and an under-documented modifier 25 is one of the most common preventable denials in dermatology.
- Appeal systematically. Industry-wide, roughly 40 to 45% of appealed denials succeed — which makes a disciplined appeals workflow one of the highest-ROI activities in the practice. Log every appeal, its outcome, and the recovered dollars so the labor cost shows a return.
Set a target net collection rate (net collections divided by contracted allowable amount) and watch it monthly by payer. A slow three-point slide at your largest payer is a five-figure annual problem wearing camouflage.
Mohs Surgery: Price the Case, Not the Day
Mohs looks lucrative on a per-encounter basis — the first-stage codes reimburse in the high hundreds of dollars per stage, with additional stages paying in the mid-hundreds — but the trend lines demand respect. Beyond the long inflation-adjusted decline, Medicaid reimbursement for Mohs stages has fallen roughly 18 to 33% depending on the code over recent multi-year windows, with the steepest drops in the last few years. A Mohs program managed on vibes will feel profitable long after the per-case margin has thinned.
Run Mohs as its own business-within-the-business:
- Know your fully loaded cost per case. Histotech wages and benefits, slide supplies and stains, equipment service contracts, the surgeon's allocated time, and the room's share of rent — divided by cases per month. Compare that against average collected revenue per case by payer, not billed charges.
- Track stages per case and the repair mix. Additional stages pay at their own rates, and reconstruction economics change sharply with complexity. A simple closure, an intermediate repair, and a flap or graft are different products with different margins; your books should say which mix you actually performed.
- Watch the multiple-procedure payment reduction. When Mohs and same-day reconstruction hit one claim, reduction rules can discount part of the work. Some practices find that scheduling reconstruction on a subsequent day changes the math — a clinical decision first, but one your per-case numbers should inform.
- Benchmark against your own history quarterly. With reimbursement drifting down, a flat cost per case is a declining margin. Quarterly trend lines catch this; annual reviews discover it a year late.
Cosmetic: Run Your Highest-Margin Business With Cash-Business Discipline
Cosmetic dermatology has no payers, no allowables, and no denials — which tempts owners to run it casually. That is backwards: the cash business deserves the tightest controls because every leaked dollar comes straight out of your highest-margin revenue.
- Prepaid packages are deferred revenue, not income. When a patient buys a six-session laser package upfront, you owe six sessions. Book the cash to a liability account and recognize revenue as sessions are delivered. Recognizing it all on day one overstates the month, understates the next five, and makes package-heavy months look like growth that never repeats.
- Gift cards and unredeemed deposits are liabilities too. Track issuance, redemption, and breakage by state escheatment rules — unclaimed-property law applies to medical spas the same as any retailer.
- Price devices by cost per procedure. A laser is not a prestige purchase; it is a per-shot manufacturing cost. Divide purchase price plus service contract plus consumables by realistic lifetime procedure volume, add staff time and room overhead, and you have a floor price. Benchmarking work has shown procedure rooms running dramatically lower overhead than general exam rooms — but only if utilization stays high. An idle device inverts that math fast.
- Separate the money flows. Cosmetic should have clean merchant-account reporting with no insurance payments mixed in, and refunds and chargebacks should post against cosmetic revenue — not vanish into a generic adjustment account.
Retail Sunscreen and Cosmeceuticals: It Is a Store, So Book It Like One
The display wall of sunscreen near your checkout is a retail business, and retail businesses live or die on inventory accounting. Three rules keep it honest:
- Capitalize inventory; expense cost of goods sold at sale. Product purchases go to an inventory asset account, and each sale moves that unit's cost to COGS. Expensing purchases when bought makes stocking months look terrible and selling months look miraculous — and hides shrinkage entirely.
- Count the shelves quarterly. Shrinkage — expired product, damaged units, staff demo use, and plain disappearance — is real in every dispensing practice. Write-offs to a shrinkage account, reviewed quarterly, tell you whether the line is actually profitable or just feels that way.
- Collect and remit sales tax like any retailer. Most states require a retail sales-tax license to dispense products, and the tax treatment of services versus products often differs — some states tax the product sale but not the facial it accompanies. If you sell online, marketplace and shipping rules add nexus questions. Get the license before the first sale, not after the first notice.
Retail also rewards bundling: packaging post-procedure skincare with the procedure itself raises per-encounter revenue on both sides. When you bundle, split the revenue between cosmetic services and retail at consistent internal prices so each center's margin stays meaningful.
The Dermatopathology Lab Decision, in Numbers
Reading your own slides converts a reference-lab expense into lab revenue — professional-component fees your dermatopathologist earns plus, where structure allows, the technical component. Whether that trade pays depends on volume, and your books should answer it before you sign equipment leases:
- Model the crossover point. Fixed costs (histology staff, equipment, lab space, CLIA and accreditation compliance) divided by per-specimen contribution margin (collected lab revenue minus variable supplies and courier savings) gives the monthly specimen count where in-house breaks even. Below that count, the reference lab is cheaper no matter how the gross revenue looks.
- Keep lab revenue and lab cost in one center. The classic mistake is booking lab collections as practice revenue while lab payroll hides in general staffing — which makes the lab look free and the clinic look expensive.
- Budget compliance as a real line item. Lab regulation, billing compliance review, and the legal structure review for self-referral rules are not optional extras; they are part of the lab's fully loaded cost and belong in the crossover math.
The Monthly Close That Keeps All of It Honest
Tie the centers together with a close checklist that runs the same way every month:
- Reconcile every money pipe — clearinghouse deposits to bank, merchant processor to bank, retail POS to bank. Unreconciled cosmetic cash is where skimming and honest mistakes both hide.
- Post contractual adjustments by payer and center, never as a plug number. The adjustment detail is your payer-negotiation ammunition.
- Review the per-center dashboard: net collection rate, denial rate, days in A/R, direct margin, fully loaded margin, revenue per encounter.
- Compare against two benchmarks: your own trailing twelve months, and industry targets — including the widely cited goal of sustaining adjusted EBITDA margins around 20% or better, below which excess administrative overhead is the usual suspect.
- Age the receivables honestly. Insurance A/R over 90 days and patient-balance A/R over 60 days need action plans with owners and dates, not just monitoring.
One structural note for growing practices: mid-level providers — physician assistants and nurse practitioners — have become genuine profit centers in dermatology as the physician-to-mid-level staffing mix has shifted over the past decade. That only works financially when their production and their fully loaded cost (salary, benefits, malpractice, supervision time) are tracked per provider. A mid-level generating strong collections against an untracked supervision burden is another version of the blended-P&L illusion.
Keep Your Multi-Center Practice Organized From Day One
Running medical, Mohs, cosmetic, retail, and lab as distinct profit centers means your transaction volume multiplies — five revenue streams, five cost structures, and one shared overhead pool to allocate fairly. That is exactly the kind of complexity where plain-text accounting shines: every entry is transparent, version-controlled, and auditable, so your per-center margins are provable numbers instead of spreadsheet folklore. Beancount.io gives you that foundation, with Fava dashboards that make per-center trends easy to review at a glance. Get started for free and see why finance-minded practice owners are switching to plain-text accounting.




